Literature DB >> 11872892

Clinical and imaging findings in cryptogenic stroke patients with and without patent foramen ovale: the PFO-ASA Study. Atrial Septal Aneurysm.

C Lamy1, C Giannesini, M Zuber, C Arquizan, J F Meder, D Trystram, J Coste, J L Mas.   

Abstract

BACKGROUND AND
PURPOSE: Patent foramen ovale (PFO) has been identified as a potential risk factor for stroke, but the mechanisms of PFO-associated stroke remain unsettled. The aim of our study was to evaluate possible differences in stroke risk factors and stroke patterns between patients with and without PFO that may give clues to the mechanism of PFO-associated stroke.
METHODS: This prospective, multicentric study involved 581 young cryptogenic stroke patients. The presence of PFO and atrial septal aneurysm was assessed by transesophageal echocardiography and reviewed independently by 2 experienced sonographers. Clinical, brain, and vascular imaging findings were reviewed by 2 neurologists and 2 neuroradiologists.
RESULTS: Of the 581 stroke patients, 267 (45.9%) had PFO. Patients with PFO were younger (OR, 0.95; 95% CI, 0.93 to 0.97) and less likely to have traditional risk factors such as hypertension (OR, 0.49; 95% CI, 0.28 to 0.85), hypercholesterolemia (OR, 0.56; 95% CI, 0.34 to 0.93), or current smoking (OR, 0.67; 95% CI, 0.47 to 0.97). Features suggestive of paradoxical embolism, such as Valsalva-provoking activities or deep vein thrombosis, were not more frequent in patients with PFO. Migraine was more common in patients with PFO (27.3%) than in those without PFO (14.0%). PFO (OR, 1.75; 95% CI, 1.08 to 2.82), particularly when associated with atrial septal aneurysm (OR, 2.71; 95% CI, 1.36 to 5.41), was significantly associated with migraine after adjustment for age and sex.
CONCLUSIONS: Differences in stroke risk factors and stroke patterns suggest that different stroke mechanisms occur in patients with and without PFO. PFO is significantly and independently associated with migraine, and this association is even stronger in patients with PFO and atrial septal aneurysm.

Entities:  

Mesh:

Year:  2002        PMID: 11872892     DOI: 10.1161/hs0302.104543

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  97 in total

1.  A neurosurgical presentation of patent foramen ovale with atrial septal aneurysm.

Authors:  Katie Walsh; Chandrasekaran Kaliaperumal; Gerry Wyse; George Kaar
Journal:  BMJ Case Rep       Date:  2011-07-20

2.  A suspected case of paradoxical renal embolism through the patent foramen ovale.

Authors:  Masaki Iwasaki; Nobuhiko Joki; Yuri Tanaka; Hidehiko Hara; Makoto Suzuki; Hiroki Hase
Journal:  Clin Exp Nephrol       Date:  2010-10-20       Impact factor: 2.801

3.  Paradoxical air embolism following contrast material injection through power injectors in patients with a patent foramen ovale.

Authors:  Kalpana Yeddula; Iftikhar Ahmad; Shafaath Husain Syed Mohammed; Sandeep Hedgire; Vikram Venkatesh; Suhny Abbara; Sanjeeva P Kalva
Journal:  Int J Cardiovasc Imaging       Date:  2012-12       Impact factor: 2.357

4.  The management of patients with patent foramen ovale and stroke.

Authors:  Irene Meissner
Journal:  Curr Treat Options Neurol       Date:  2005-11       Impact factor: 3.598

Review 5.  [Patent foramen ovale, atrial septum aneurysm, and stroke. An examination of the status of recent evidence].

Authors:  K Kraywinkel; M Jauss; H-C Diener; C Weimar
Journal:  Nervenarzt       Date:  2005-08       Impact factor: 1.214

Review 6.  Atrial cardiopathy: a mechanism of cryptogenic stroke.

Authors:  Shadi Yaghi; Hooman Kamel; Mitchell S V Elkind
Journal:  Expert Rev Cardiovasc Ther       Date:  2017-07-27

7.  The relationship between migraine and right-to-left shunt in children.

Authors:  Sevcan Sarısoy; Ömer Faruk Aydın; Metin Sungur; Ilkay Koray Bayrak; Servet Aker; Hamit Özyürek; Haydar Ali Taşdemir; Kemal Baysal
Journal:  Eur J Pediatr       Date:  2010-09-28       Impact factor: 3.183

Review 8.  Is patent foramen ovale a modifiable risk factor for stroke recurrence?

Authors:  David M Kent; David E Thaler
Journal:  Stroke       Date:  2010-10       Impact factor: 7.914

Review 9.  The management of cryptogenic stroke in pregnancy.

Authors:  E A Orchard; N Wilson; O J M Ormerod
Journal:  Obstet Med       Date:  2011-03-01

10.  Transcatheter Closure of Intracardiac Shunts.

Authors:  David T. Balzer
Journal:  Curr Treat Options Cardiovasc Med       Date:  2004-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.